How many institutions held INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value in Q3 2023?

10 institutional investors reported INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value for Q3 2023. Use the holders table for investor-level position and value details.

INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS)

Q: What does CUSIP 45828J103 represent in this 13F holders report?

CUSIP 45828J103 is the security identifier for INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 45828J103

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 48,324,727
Total 13F shares: 298,447
Share change: +269,884
Total reported value: $1,190,347
Price per share: $3.97
Number of holders: 10
Value change: +$1,020,510
Number of buys: 9
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 45828J103?
CUSIP 45828J103 identifies INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 45828J103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Walleye Capital LLC	13F	Company	0.06%	28,363	$169,043	—	30 Jun 2023	13F
Glassman Wealth Services	13F	Company	0%	200	$1,192	—	30 Jun 2023	13F

Institutional Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q3 2023

As of 30 Sep 2023, INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 298,447 shares. The largest 10 holders included HOHIMER WEALTH MANAGEMENT, LLC, Sigma Planning Corp, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., WELLS FARGO & COMPANY/MN, OSAIC HOLDINGS, INC., Tower Research Capital LLC (TRC), Glassman Wealth Services, and JPMORGAN CHASE & CO. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.